4 studies found for:    24209977 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Condition: Liver Disease
Interventions: Drug: sofosbuvir/ledipasvir;   Drug: sofosbuvir;   Drug: Ribavirin
2 Recruiting Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
Condition: Hepatitis C
Intervention: Drug: Sofosbuvir and simeprevir
3 Recruiting Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs
Condition: Hepatitis C
Intervention: Drug: Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
4 Completed
Has Results
Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV

Indicates status has not been verified in more than two years